Shariq S Ansari Selected Research

erucylphospho- N,N,N- trimethylpropylammonium

1/2018	Upregulation of cell cycle genes in head and neck cancer patients may be antagonized by erufosine's down regulation of cell cycle processes in OSCC cells.
1/2018	Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells.
2/2017	Erufosine increases RhoB expression in oral squamous carcinoma cells independent of its tumor suppressive mode of action - a short report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shariq S Ansari Research Topics

Disease

2	Squamous Cell Carcinoma of Head and Neck 01/2018 - 01/2018
2	Neoplasms (Cancer) 01/2018 - 02/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2018 - 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2017

Drug/Important Bio-Agent (IBA)

3	erucylphospho- N,N,N- trimethylpropylammoniumIBA 01/2018 - 02/2017
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Cyclin D1IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	CyclinsIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 02/2017